Insights

More Articles Back to Article

Study shows low-cost arthritis drug's efficacy in blood cancers

A small British study evaluated data from 11 patients with polycythemia vera and essential thrombocythemia using the rheumatoid arthritis drug methotrexate and found that the drug improved their disease symptoms and also lowered raised blood counts, according to the British Journal of Haematology. "Given the very low cost of MTX, this research could offer an effective therapy on a budget accessible to healthcare systems throughout the world -- marking a potentially substantial clinical and health economic benefit," said study co-author Dr. Martin Zeidler of the UK's University of Sheffield. BreakingNews (Ireland) (9/17)

立即阅读整篇文章。

文章仅仅是 DIA 会员的专享福利之一。了解详情并立即加入,不再错过任何文章!